AU2010227221B2 - Combinations including pneumococcal serotype 14 saccharide - Google Patents

Combinations including pneumococcal serotype 14 saccharide Download PDF

Info

Publication number
AU2010227221B2
AU2010227221B2 AU2010227221A AU2010227221A AU2010227221B2 AU 2010227221 B2 AU2010227221 B2 AU 2010227221B2 AU 2010227221 A AU2010227221 A AU 2010227221A AU 2010227221 A AU2010227221 A AU 2010227221A AU 2010227221 B2 AU2010227221 B2 AU 2010227221B2
Authority
AU
Australia
Prior art keywords
seq
los
composition according
meningococcal
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010227221A
Other languages
English (en)
Other versions
AU2010227221A1 (en
Inventor
Paolo Costantino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2010227221A1 publication Critical patent/AU2010227221A1/en
Application granted granted Critical
Publication of AU2010227221B2 publication Critical patent/AU2010227221B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2010227221A 2009-03-24 2010-03-24 Combinations including pneumococcal serotype 14 saccharide Ceased AU2010227221B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16299609P 2009-03-24 2009-03-24
US61/162,996 2009-03-24
PCT/IB2010/000735 WO2010109325A2 (en) 2009-03-24 2010-03-24 Combinations including pneumococcal serotype 14 saccharide

Publications (2)

Publication Number Publication Date
AU2010227221A1 AU2010227221A1 (en) 2011-10-13
AU2010227221B2 true AU2010227221B2 (en) 2015-01-22

Family

ID=42352288

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010227221A Ceased AU2010227221B2 (en) 2009-03-24 2010-03-24 Combinations including pneumococcal serotype 14 saccharide

Country Status (9)

Country Link
US (1) US20120064104A1 (enExample)
EP (1) EP2411044A2 (enExample)
JP (2) JP5806204B2 (enExample)
CN (1) CN102421449A (enExample)
AU (1) AU2010227221B2 (enExample)
CA (1) CA2756398A1 (enExample)
NZ (1) NZ595223A (enExample)
RU (2) RU2549438C2 (enExample)
WO (1) WO2010109325A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1179072A2 (en) 1999-05-19 2002-02-13 Chiron S.P.A. Combination neisserial compositions
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
KR20140033127A (ko) 2011-05-17 2014-03-17 글락소스미스클라인 바이오로지칼즈 에스.에이. 스트렙토코쿠스 뉴모니애에 대한 백신
CN104428008B (zh) 2012-05-24 2020-10-09 美国政府(由卫生和人类服务部的部长所代表) 多价脑膜炎球菌缀合物及制备缀合物的方法
ES2847923T3 (es) * 2012-06-14 2021-08-04 Glaxosmithkline Biologicals Sa Vacunas contra el meningococo del serogrupo X
CN104736563A (zh) 2012-07-27 2015-06-24 国家健康与医学研究院 Cd147作为受体用于脑膜炎球菌至血管内皮的菌毛介导的粘附
IL312327B2 (en) * 2014-01-21 2026-02-01 Pfizer Immunogenic preparations comprising conjugated capsular saccharide antigens and their uses
US20150344530A1 (en) * 2014-05-29 2015-12-03 Subhash V. Kapre Synthetic Peptides as Carriers for Conjugation with Polysaccharides
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
WO2023132795A2 (en) * 2022-01-05 2023-07-13 National University Of Singapore Modified bacterial glycans and conjugates thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014418A2 (en) * 2002-08-02 2004-02-19 Glaxosmithkline Biologicals S.A. Neisserial vaccine compositions comprising a combination of antigens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5792920B2 (ja) * 2005-12-22 2015-10-14 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014418A2 (en) * 2002-08-02 2004-02-19 Glaxosmithkline Biologicals S.A. Neisserial vaccine compositions comprising a combination of antigens

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GERMIE, P. J. M. et al., Vaccine, 2007, vol. 25, pages 2491-2496 *

Also Published As

Publication number Publication date
CN102421449A (zh) 2012-04-18
JP2015163651A (ja) 2015-09-10
JP5806204B2 (ja) 2015-11-10
RU2011142747A (ru) 2013-04-27
WO2010109325A3 (en) 2011-01-20
US20120064104A1 (en) 2012-03-15
CA2756398A1 (en) 2010-09-30
EP2411044A2 (en) 2012-02-01
RU2549438C2 (ru) 2015-04-27
AU2010227221A1 (en) 2011-10-13
RU2014122163A (ru) 2015-12-10
NZ595223A (en) 2013-12-20
JP2012521404A (ja) 2012-09-13
WO2010109325A2 (en) 2010-09-30

Similar Documents

Publication Publication Date Title
AU2010227220B2 (en) Combinations of meningococcal factor H binding protein and pneumococcal saccharide conjugates
US20120064104A1 (en) Combinations including pneumococcal serotype 14 saccharide
AU2011268507B2 (en) Combinations of meningococcal factor H binding proteins
AU2010310985B2 (en) Modified meningococcal fHBP polypeptides
EP2470204B1 (en) Hybrid polypeptides including meningococcal fhbp sequences
US12415838B2 (en) Modified meningococcal fHbp polypeptides
US20100189737A1 (en) Meningococcal vaccines including hemoglobin receptor
US20130022639A1 (en) Expression of meningococcal fhbp polypeptides
EP3263591A1 (en) Meningococcal fhbp polypeptides
AU2014268243B2 (en) Combinations of meningococcal factor H binding protein and pneumococcal saccharide conjugates
AU2016273825A1 (en) Modified meningococcal fHBP polypeptides
AU2015200160A1 (en) Modified meningococcal fHBP polypeptides
AU2013202606A1 (en) Combinations of meningococcal factor H binding proteins

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired